Bruker, Agilent Reach Deal on Varian Product Lines Purchase
March 10, 2010
Bruker, Agilent Reach Deal on Varian Product Lines Purchase
The sale of the product lines to Bruker will clear the way for Agilent to complete its $1.5 billion acquisition of Varian, which is now expected by the end of April.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Bruker Completes Acquisition of Varian Product Lines
May 20, 2010 / GenomeWeb Daily News - Agilent Expects Varian to Add $111M to Life-Sci Arm's H2 Revenue, May Be a Year for Large M&A
May 21, 2010 / ProteoMonitor - Bruker Forms New Chemical Analysis Division
April 1, 2010 / GenomeWeb Daily News - Bruker Completes $37.5M Acquisition of Three Varian Product Lines from Agilent
May 21, 2010 / ProteoMonitor - Agilent Completes Varian Acquisition
May 17, 2010 / GenomeWeb Daily News